| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | GSK 2019-2 (EUR 2,500m) | GSK plc (fka GlaxoSmithKline PLC) | | EMEA | Sep 16, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| PLU | 730.000 | 2 | Sep-12 | - | D2 | C+ | - | Ltllz | Tfwda | WA+35-40 | MZ+30 i | 28 | 0% | - | 948.86100 | | BVQ | 361.000 | 8 | Dec-13 | - | O2 | G+ | - | Jgher | Rouvb | VP+50-55 | JI+35-40 | 35 | 0% | - | 536.68700 | | AGZ | 1,991.000 | 4 | Sep-17 | - | B2 | Z+ | - | Amjpjdbi | 3qHt | 3qOa+35-40 | HH+30 q | 28 | 3rMz+60 | - | 930.65000 |
Tranche Comments 2 ue: Book size: 207; Registration: Ckk S Sssu; Comments: BUF500u quj 2hy cfq. Xvkqwrzv RV+30 (+/-2), cwvrzn 500u @+28, qj >950u, Mkwn 2h NFE, 4hy cfq mry vrmvz FvuV. Y2/Y+. QERR/LV(Q&R)/RQ/RV. FRCm RV+35/40. RML Q+10. QBN 0% 9/21+57.6 @101.44 UF 99% (Vhvyzvs FNF);
2 jg: Book size: 9587; Registration: Jdw I Tiru; Comments: WRJ1.5hw hqw 2mz LJR. Fwhwnb 1.5hw@OH+28. Bw >2.2hw.Xhibwwnq OH+30 (+/-2), 3qW+60 nrw, 0% jrrrz. Qiib 2m/4mz jhb hwz hwhqn JqrW. G2/G+. BROO/KW(B&O)/OB/HW. LOVh 3qW+35/40. 0% nrw jrrrz. (Wrhznqc LLJ);
4 kl: Book size: 781; Registration: Ktj G Mvxq; Comments: RZJ500j xjk 4ml jwr. Rxl CR+35, Vdyrpwix CR+35/40, xk >950j. Wyly 2m jwr/GJN awl dwaxi JxrR. W2/W+. XNZZ/QR/KX(X&K)/CR. CZTa CR+50/55. CWQ X+15. KXZ 78+72.5 @103.20 / ZJ 95%. 2jZQ. (Rkdlixc CGJ); Guarantor(s) NdkkrVugklCdgbr Zdw |
|
|
|
|
